Skip to main content

Rosanna Paciucci Barzanti

Institutions of which they are part

Main researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Rosanna Paciucci Barzanti

Institutions of which they are part

Main researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Projects

Estudio de la modulación de la proliferación y progresión tumoral medida por PTOV1; interacción con las rutas de IGF-1, Notch y Wnt y expresión en tissue-arrays de tumores.

IP: Rosanna Paciucci Barzanti
Collaborators: Inés de Torres Ramirez, Marta Sese Faustino
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 181500
Reference: SAF2008-03936
Duration: 01/01/2009 - 30/06/2012

Ministerio de Ciencia

Función de la proteina PTOV1 y de los complejos que forma con RACK1 y/o PAR-6 en la proliferación/movilidad/invasión celular

IP: Rosanna Paciucci Barzanti
Collaborators: -
Funding agency: Fundació Institut de Recerca HUVH
Funding:
Reference: PRED/IR-HUVH/11/2006
Duration: 01/01/2007 - 31/12/2010

Función del complejo PTOV1/flotilina-1/RACK1 en la proliferación y progresión tumoral. Validación in vivo sobre tissue-arrays de tumores humanos y en el modelo murino TRAMP de cáncer de próstata.

IP: Rosanna Paciucci Barzanti
Collaborators: -
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 53000
Reference: BES-2006-12043
Duration: 01/09/2006 - 31/08/2010

Ministerio de Ciencia

RTICC - Red Temática de Investigación cooperativa de cáncer

IP: Jaume Reventós Puigjaner
Collaborators: Joan Morote Robles, Ma Teresa Quiles Pérez, Francina Munell Casadesus, Eva Colas Ortega, Enric Trilla Herrera, Silvia Cabrera Diaz, Antonio Gil Moreno, Marta Rebull Santamaria, Tomàs Pinós Figueras, Rosanna Paciucci Barzanti, Marina Rigau Resina, Carles Xavier Raventós Busquets, Maria Antonia Arbos Via, Jacques Planas Morin, Josep Roma Castanyer
Funding agency: Instituto de Salud Carlos III
Funding: 350549.54
Reference: RD06/0020/0058
Duration: 02/01/2007 - 31/12/2013

Related news

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

During the last year, the collaboration between Vall d’Hebron and ZeClinics has found three nanobody candidates with potent anticancer properties in zebrafish model.

Related professionals

Cesar W Ruiz Campillo

Cesar W Ruiz Campillo

Main researcher
Read more
Luciano Rodríguez Gómez

Luciano Rodríguez Gómez

Senior researcher
Transfusional Medicine
Read more
Marta Rebull Santamaria

Marta Rebull Santamaria

Research technician
Biomedical Research in Gynaecology
Read more
Marc Aguilar García

Marc Aguilar García

Reconstructive Surgery of the Locomotor System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.